PA-SALADAX-BIOMEDICAL
Saladax Biomedical, Inc. (Saladax) is pleased to announce that it has acquired a patent portfolio for antipsychotic drug testing from Janssen Pharmaceutica NV. This intellectual property (IP) portfolio includes 17 patent families and has resulted in 33 U.S. patents and 296 patents in ex-U.S. countries. This IP, along with the current Saladax IP, covers the major antipsychotic drugs that are prescribed worldwide and places Saladax in a premier position in the antipsychotic drug testing field.
With this IP portfolio, Saladax has developed tests for chemistry analyzers commonly found in hospitals and a point-of-care instrument that can be used where centralized testing is not possible. These tests address a significant unmet clinical need for patients with serious mental illness (SMI) by providing rapid, actionable results to health care professionals (HCP). International and U.S. clinical guidelines have recently been established recommending antipsychotic drug testing. The availability of these tools will greatly enhance the ability of health care professionals to better manage their patients in real time.
SMI is a significant public health concern. The estimated economic impact of SMI worldwide is more than $2.5 trillion each year with the number of people that SMI affects growing rapidly. In the U.S. current data shows that more than 13 million adults in the U.S. experienced SMI in the past year. That is more than 3% of the adult population.1
Saladax is well positioned as the leading diagnostic company in the field of antipsychotic drug testing with a full panel of antipsychotic tests already on the market and a solid pipeline of new products.
“This is a very exciting time for Saladax and the field of therapeutic drug monitoring (TDM).” stated Sal Salamone, Founder and CEO of Saladax. “The availability of antipsychotic testing is arguably the most significant step in the field of TDM since the launch of the Abbott Diagnostics TDx platform back in the 1980’s.”
About Saladax Biomedical, Inc.
Headquartered in Bethlehem, PA, Saladax Biomedical, Inc. is a privately held company that develops, manufactures, and markets assays that provide rapid therapeutic drug levels for essential and life-saving medicines prescribed by psychiatrists and oncologists. Since 2007, Saladax's proprietary technology has been used in clinical laboratories or point-of-care settings to assist clinicians in monitoring and optimizing patient care. Additionally, the company collaborates with leading pharmaceutical companies to develop tests for clinical trials and companion diagnostics. For more information, visit MyCareTests.com .
- Substance Abuse and Mental Health Services Administration. (2020). Key substance use and mental health indicators in the United States: Results from the 2019 National Survey on Drug Use and Health (HHS Publication No. PEP20-07-01-001, NSDUH Series H-55) . Rockville, MD: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration.
- Bessonova L, Ogden K, The Economic Burden of Bipolar Disorder in the United States: A Systematic Literature review 2011. doi: 10.2147/CEOR.S259338
View source version on businesswire.com: https://www.businesswire.com/news/home/20220405005008/en/
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Biedermann Medtech Group Announces Transformation of U.S. Spine Market Approach and New Business Model28.8.2025 18:00:00 CEST | Press release
The Biedermann Medtech Group, the prominent innovator in next generation spinal and extremity implant systems and procedural solutions, today announced a strategic transformation of its U.S. operations. Biedermann will expand its focus beyond product distribution to a broader platform of integrated services and solutions designed to reshape its U.S. business model. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250828746562/en/ As part of this transition, Biedermann Motech will discontinue to directly distribute its product lines of advanced solutions for spinal and extremity surgery in the U.S. market in the near future. This decision follows a comprehensive and detailed review of market dynamics and recent macro-economic developments. In the next phase of this transformation, Biedermann Motech will leverage its strategic partnership with intellectual property powerhouse and recognized innovation leader Biedermann Technolog
Stonebranch Named a Leader in the 2025 Gartner® Magic Quadrant™ for Service Orchestration and Automation Platforms (SOAPs)28.8.2025 17:49:00 CEST | Press release
Stonebranch recognized for the second consecutive year in the Leaders’ Quadrant for Completeness of Vision and Ability to Execute. Stonebranch, a leading provider of service orchestration and automation solutions, today announced that it has once again been positioned by Gartner as a Leader in the Magic Quadrant for Service Orchestration and Automation Platforms (SOAPs) for its offering, Universal Automation Center (UAC).1 The evaluation reflects Stonebranch’s completeness of vision and ability to execute. “We’re proud to be recognized as a Leader for the second year in a row,” said Giuseppe Damiani, CEO at Stonebranch. “We believe this recognition validates our strategy of enabling enterprises to embrace real-time, event-driven orchestration. Our customers rely on UAC to unify their automation landscape, scale operations securely, and drive digital transformation with confidence.” Stonebranch helps enterprises modernize IT automation across hybrid and multi-cloud environments with a n
Transition Industries Awards Techint E&C and Siemens Energy a FEED Contract for a 210 MW Electrolyzer Facility for the Pacifico Mexinol Project28.8.2025 15:00:00 CEST | Press release
Transition Industries LLC, a developer of world-scale, net-zero carbon emissions methanol and hydrogen facilities, has awarded Siemens Energy and Techint Engineering & Construction a Front-End Engineering Design (FEED) contract for an approximately 210 MW Elyzer P-300 electrolyzer facility as part of its 6,130 MT per day ultra-low carbon methanol Pacifico Mexinol project in Sinaloa, Mexico. The FEED study marks the next step in the expanding partnership between Transition Industries, Techint Engineering & Construction, and Siemens Energy, who intend to leverage their advanced technology and services to ensure the highest standards of efficiency and reliability in green hydrogen production. Under the terms of the FEED Agreement, Siemens Energy and Techint Engineering & Construction will provide an initial binding not-to-exceed Lump Sum Firm Price, followed by a final binding Lump Sum Turnkey Firm Price for the Engineering, Procurement and Construction (EPC) of the electrolyzer facility.
The Marriott Vacation Clubs™ Expands in Asia Pacific with New Resort in Khao Lak, Thailand and Growth in Bali and Shanghai28.8.2025 15:00:00 CEST | Press release
Marriott Vacation Club, Khao Lak Beach Resort marks the brand’s seventh vacation ownership resort in Asia Pacific, reinforcing growing demand across the region The Marriott Vacation Clubs™, a collection of vacation ownership brands under Marriott Vacations Worldwide Corporation, is expanding its presence in Asia Pacific with the opening of Marriott Vacation Club, Khao Lak Beach Resort in Thailand this August. The new resort is part of broader regional growth, that includes a new development at Marriott’s Enclave at Bali Nusa Dua Terrace and new apartments at Marriott’s Bali Nusa Dua Terrace, as well as the expansion of The Marriott Vacation Club’s marketing call center in Shanghai. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250827472037/en/ Marriott Vacation Club, Khao Lak Beach Resort provides scenic views of the Andaman Sea. Photograph depicts the JW Marriott, Khao Lak Resort & Spa. “Our continued investment in Asia Pa
Eaton and ChargePoint Launch Breakthrough Ultrafast DC V2X Chargers and Power Infrastructure to Accelerate the Future of EV Charging28.8.2025 14:33:00 CEST | Press release
Modular and DC Grid design can be deployed with 30% lower capex in a 30% smaller footprint while delivering up to a 30% reduction in ongoing operational costs, compared to other available solutionsJoint solution debuts at the RE+ trade show September 9, where Eaton will demonstrate broad capabilities advancing electrification and energy transition Intelligent power management company Eaton, together with ChargePoint, a leading provider of electric vehicle (EV) charging solutions, today announced an ultrafast charging architecture with end-to-end power infrastructure for public charging and fleets. ChargePoint Express Grid, powered by Eaton, is a vehicle-to-everything (V2X) capable solution that delivers up to 600kW of power for passenger EVs and can provide megawatt charging for heavy-duty commercial applications. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250827710125/en/ Eaton and ChargePoint announce ultrafast DC char
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom